Abstract
Severe or even mild hyperhomocysteinaemia can cause a wide range of neurological problems. In recent years its vascular complications, including cerebral stroke, in children and young adults have gained special interest, because hyperhomocysteinaemia is treatable and recurrence of vascular incidents may be preventable. Current knowledge about biochemical mechanisms leading to hyperhomocysteinaemia, the pathogenesis of vascular pathology and neurological disfunction, and the various patterns of cerebral damage are reviewed. The significance of MRI in diagnosis, follow-up and research on hyperhomocysteinaemia is discussed.
Similar content being viewed by others
References
Carson NAJ, Neill DW (1962) Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch Dis Child 37: 505–513
Natowicz M, Kelley RI (1987) Mendelian etiologies of stroke. Ann Neurol 22:175–192
Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GHJ, Bromberg IL, Cerone R, Fowler B, Gröbe H, Schmidt H, Schweitzer L (1985) The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 37:1–31
Mudd SH, Levy HL, Skovby F (1989) Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 693–734
Rosenblatt DS (1989) Inherited disorders of folate transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 2049–2064
Fenton WA, Rosenberg LE (1989) Inherited disorders of cobalamin transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 2065–2082
Tada K, Tateda H, Arashima S, Sakai K, Kitagawa T, Aoki K, Suwa S, Kawamura M, Oura T, Takesada M, Kuroda Y, Yamashita F, Matsuda I, Naruse H (1984) Follow-up study of a nation-wide neonatal metabolic screening program in Japan. Eur J Pediatr 142: 204–207
Skovby F, Krassikoff N, Francke U (1984) Assignment of the gene for cystathionine β-synthase to human chromosome 21 in somatic cell hybrids. Hum Genet 65:291–294
Watkins D, Rosenblatt DS (1988) Genetic heterogeneity among patients with methylcobalamin deficiency. Definition of two complementation groups, cblE and cblG. J Clin Invest 81:1690–1694
Fenton WA, Rosenberg LE (1978) Genetic and biochemical analyses of human cobalamin mutants in cell culture. Ann Rev Genet 12:223–248
Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, deGarmo P (1990) Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 21:572–576
Mölgaard J, Malinow MR, Lassvik C, Holm AC, Upson B, Olsson AG (1992) Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication. J Int Med 231:273–279
Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH (1992) A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268: 877–881
Boers GHJ, Smals AGH, Trijbels FJM, Fowler B, Bakkeren JAJM, Schoonderwaldt HC, Kleijer WJ, Kloppenborg PWC (1985) Heterozygosity of homocytinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 313:709–715
Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324:1149–1155
Brattström L, Lindgren A (1992) Hyperhomocysteinemia as a risk factor for stroke. Neur Res 14:81–84
Franken DG, Boers GHJ, Blom HJ, Trijbels JMF, Kloppenborg PWC (1994) Treatment of mild hyperhomocysteinemia in vascular patients. Arterioscler Thromb 14:465–470
Ueland PM, Refsum H, Brattström L (1992) Plasma homocysteine and cardiovascular disease. In: Francis RB Jr (ed) Artherosclerotic cardiovascular disease, hemostasis, and endothelial function. Marcel Dekker, New York, pp 183–236
Boers GHJ, Fowler B, Smals AGH, Trijbels JMF, Leermakers AL, Kleijer WJ, Kloppenborg PWC (1985) Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts. Hum Genet 69:164–169
Kang SS, Wong PKW, Bock HG, Horwitz A, Grix A (1991) Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. Am J Hum Genet 48:546–551
Kang SS, Wong PKW, Susmano A, Sora J, Norusis M, Ruggie N (1991) Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 48:536–545
Stabler SP, Marcell PD, Podell ER, Allen RH, Savage DG, Lindenbaum J (1988) Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 81:466–474
Wilcken DEL, Dudman NPB, Tyrrell PA, Robertson MR (1988) Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease. Metabolism 37:697–701
Hultberg B, Agardh E, Andersson A, Brattström L, Isaksson A, Israelsson B, Agardh CD (1991) Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type I diabetes mellitus. Scand J Clin Lab Invest 51:277–282
Ueland PM, Refsum H (1989) Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease and drug therapy. J Lab Clin Med 114: 473–501
Skovby F (1985) Homocystinuria: Clinical, biochemical and genetic aspects of cystathionine β-synthase and its deficiency in man. Acta Paediatr Scand (Suppl) 321:1–21
Brett EM (1966) Homocystinuria with epilepsy. Proc Roy Soc Med 59:484–487
Grieco AJ (1977) Homocystinuria: pathogenetic mechanism. Am J Med Sci 273:120–132
Abbott MH, Folstein SE, Abbey H, Pyeritz RE (1987) Psychiatric manifestations of homocystinuria due to cystathionine β-synthase deficiency: prevalence, natural history, and relationship to neurological impairment and vitamin B6-responsiveness. Am J Med Genet 26:959–969
Davous P, Rondot P (1983) Homocystinuria and dystonia (letter). J Neurol Neurosurg Psychiatry 46:283
Kempster PA, Brenton DP, Gale AN, Stern GM (1988) Dystonia in homocystinuria. J Neurol Neurosurg Psychiatry 51:859–862
Shih VE, Salam MZ, Mudd SH, Uhlendorf BW, Adams RD (1972) A new form of homocystinuria due to N5N10-methylenetetrahydrofolate reductase deficiency (abstract). Pediatr Res 6: 395/135
Mudd SH, Uhlendorf BW, Freeman JM, Finkelstein JD, Shih VE (1972) Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity. Biochem Biophys Res Commun 46:905–912
Christensen E, Brandt NJ (1985) Prenatal diagnosis of 5,10-methylenetetrahydrofolate reductase deficiency (letter) N Engl J Med 313:50–51
Visy JM, LeCoz P, Chadefaux B, Fressinaud C, Woimant F, Marquet J, Zittoun J, Visy J, Vallat JM, Haguenau M (1991) Homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency revealed by stroke in adult siblings. Neurology 41:1313–1315
Cochran FB, Packman S (1992) Homocystinuria presenting as sagittal sinus thrombosis. Eur Neurol 32:1–3
Nishimura M, Yoshino K, Tomita Y, Takashima S, Tanaka J, Narisawa K, Kurobane I (1985) Central and peripheral nervous system pathology of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Pediat Neurol 1:375–378
Haworth JC, Dilling LA, Surtees RAH, Seargeant LE, Lue-Shing H, Cooper BA, Rosenblatt DS (1993) Symptomatic and asymptomatic methylenetetrahydrofolate reductase deficiency in two adult brothers. Am J Med Genet 45:572–576
Cooper BA, Rosenblatt DS (1987) Inherited defects of vitamin B12 metabolism. Ann Rev Nutr 7:291–320
Carmel R, Watkins D, Goodman SI, Rosenblatt DS (1988) Hereditary defect of cobalamin metabolism (cblG mutation) presenting as a neurologic disorder in adulthood. N Engl J Med 318:17380–1741
Mitchell GA, Watkins D, Melançon SB, Rosenblatt DS, Geoffroy G, Orquin J, Barsoum Homsy M, Dallaire L (1986) Clinical heterogeneity in cobalamin C variant of combined homocystinuria and methylmalonic aciduria. J Pediatrics 108:410–415
Shinnar S, Singer HS (1984) Cobalamin C mutation (methylmalonic aciduria and homocystinuria) in adolescence: a treatable cause of dementia and myelopathy. N Engl J Med 311: 451–454
Brattström L, Lindgren A, Israelsson B, Malinow MR, Norrving B, Upson B, Hamfelt A (1992) Hyperhomocysteinaemia in stroke: prevalence, cause, and relationship to type of stroke and stroke risk factors. Eur J Clin Invest 22: 214–221
White HH, Rowland LP, Araki S, Thompson HL, Cowen D (1965) Homocystinuria. Arch Neurol 13:455–470
Carson NAJ, Dent CE, Field CMB, Gaull GE (1965) Homocystinuria: clinical and pathological review of ten cases. J Pediatr 66:565–583
Schoonderwaldt HC, Boers GHJ, Gruysberg JRM, Schulte BPM, Slooff JL, Thijssen HOM (1981) Neurological manifestations of homocystinuria. Clin Neurol Neurosurg 83:153–162
Chou SM, Waisman HA (1965) Spongy degeneration of the central nervous system. Arch Pathol 79:357–363
Dunn HG, Perry TL, Dolman CL (1966) Homocystinuria. A recently discovered cause of mental defect and cerebrovascular thrombosis. Neurology 16:407–420
Kanwar YS, Manaligod JR, Wong PKW (1976) Morphologic studies in a patient with homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Pediatr Res 10:598–609
Wong PKW, Justice P, Hruby M, Weiss EB, Diamond E (1977) Folic acid nonresponsive homocystinuria due to methylenetetrahydrofolate reductase deficiency. Pediatrics 59:749–756
Baumgartner ER, Wick H, Ohnacker H, Probst A, Mauer R (1980) Vascular lesions in two patients with congenital homocystinuria due to different defects of remethylation. J Inher Metabl Dis 3: 101–103
Beckman DR, Hoganson G, Berlow S, Gilbert EF (1987) Pathological findings in 5,10-methylenetetrahydrofolate reductase deficiency. Birth Defects 23: 47–64
Clayton PT, Smith I, Harding B, Hyland K, Leonard JV, Leeming RJ (1986) Subacute combined degeneration of the cord, dementia, and parkinsonism due to an inborn error of folate metabolism. J Neurol Neurosurg Psychiatry 49:920–927
Dillon MJ, England JM, Gompertz D, Goodey PA, Grant DB, Hussein HAA, Linnell JC, Matthews DM, Mudd SH, Newns GH, Seakins JWT, Uhlendorf BW, Wise IJ (1974) Mental retardation, megaloblastic anaemia, methylmalonic aciduria and abnormal homocysteine metabolism due to an error in vitamin B12 metabolism. Clin Sci Mol Med 47:43–61
Erbe RW (1986) Inborn errors of folate metabolism. In: Blakeley RL, Whitehead VM (eds) Folates and pterins: nutritional, pharmalogical and physiological aspects. Vol 3. John Wiley and Sons, New York, pp 413–465
Dayan AD, Ramsey RB (1974) An inborn error of vitamin B12 metabolism associated with cellular deficiency of coenzyme forms of the vitamin. Pathological and neurochemical findings in one case. J Neurol Sci 23:117–128
Duchen LW, Jacobs JM (1992) Nutritional deficiencies and metabolic disorders. In: Adams JH, Duchen LW (eds) Greenfield's neuropathology. 5th edn. Edward Arnold, London, pp 820–834
Ludolph AC, Ullrich K, Bick U, Fahrendorf G, Przyrembel H (1991) Functional and morphological deficits in late-treated patients with homocystinuria: a clinical, electrophysiologic and MRI study. Acta Neurol Scand 83: 161–165
Mirowitz SA, Sartor K, Prensky AJ, Gado M, Hodges III FJ (1991) Neurodegenerative diseases of childhood: MR and CT evaluation. J Comput Assist Tomogr 15:210–222
Arbour L, Rosenblatt B, Clow C, Wilson GN (1988) Postoperative dystonia in a female patient with homocystinuria. J Pediatr 113:863–864
Berardelli A, Thompson PD, Zaccagnini M, Giardini O, D'Eufemia P, Massoud R, Manfredi M (1991) Two sisters with generalized dystonia associated with homocystinuria. Mov Dis 6:163–165
Rutledge JN, Hilal SK, Silver AJ, Defendini R, Fahn S (1987) Study of movement disorders and brain iron by MR. AJNR 8:397–411
Drayer BP, Olanow W, Burger P, Johnson GA, Herfkens R, Riederer S (1986) Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology 159:494–498
Surtees R, Leonard J, Austin S (1991) Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 338: 1550–1554
Bellini C, Cerone R, Bonacci W, Caruso U, Magliano CP, Serra G, Fowler B, Romano C (1992) Biochemical diagnosis and outcome of 2 years treatment in a patient with combined methylmalonic aciduria and homocystinuria. Eur J Pediatr 151:818–820
van Diemen-Steenvoorde R, van Nieuwenhuizen O, de Klerk JBC, Duran M (1990) Quasi-moyamoya disease and heterozygosity for homocystinuria in a five-year-old girl. Neuropediatr 21: 110–112
Harker LA, Harlan JM, Ross R (1983) Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. Circ Res 53: 731–739
Starkebaum G, Harlan JM (1986) Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 77: 1370–1376
Scott JM, Weir DG (1981) The methyl folate trap. Lancet ii:337–340
Scott JM, Dinn JJ, Wilson P, Weir DG (1981) Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet ii:334–337
Hyland K, Smith I, Bottiglieri T, Perry J, Wendel U, Clayton PT, Leonard JV (1988) Demyelination and decreased S-adenosylmethionine in 5,10-methylenetetrahydrofolate reductase deficiency. Neurology 38:459–462
Wwir DG, Keating S, Molloy A, McPartlin J, Kennedy S, Blanchflower J, Kennedy DG, Rice D, Scott JM (1988) Methylation deficiency causes vitamin B12-associated neuropathy in the pig. J Neurochem 51:1949–1952
Schatz RA, Wilens TE, Sellinger OT (1981) Decreased transmethylation of biogenic amines after in vivo elevation of brain S-Adenosyl-l-homocysteine. J Neurochem 36:1739–1748
Fregnan GB, Biagi G (1988) Proconvulsive and convulsive properties of methionine, homocysteine and related compounds in mice. Acta Therapeutica 14:31–43
Olney JW (1974) Toxic effects of glutamate and related aminoacids on the developing central nervous system. In: Nyhan WL (ed) Heritable disorders of amino acid metabolism. John Wiley, London, pp 501–512
Hyland K, Smith I, Howells DW, Clayton PT, Leonard JV (1985) The determination of pterins, biogenic amine metabolites and aromatic amino acids in cerebrospinal fluid using isocratic reverse phase liquid chromatography with in series dual cell coulometric electrochemical and fluorescence detection: use in a study of inborn errors of dihydropteridine reductase and 5,10-methylenetetrahydrofolate reductase. In: Wachter H, Curtius HC, Pfleiderer W (eds) Biochemical and clinical aspects of pteridins, vol 4. Walter de Gruyter, Berlin, pp 85–99
Wendel U, Bremer HJ (1984) Betaine in the treatment of homocystinuria due to 5,10 methylenetetrahydrofolate reductase deficiency. Eur J Pediatr 142: 147–150
Holme E, Kjellman B, Ronge E (1989) Betaine for treatment of homocystinuria caused by methylenetetrahydrofolate reductase deficiency. Arch Dis Child 64:1061–1064
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van den Berg, M., van der Knaap, M.S., Boers, G.H.J. et al. Hyperhomocysteinaemia; with reference to its neuroradiological aspects. Neuroradiology 37, 403–411 (1995). https://doi.org/10.1007/BF00588024
Issue Date:
DOI: https://doi.org/10.1007/BF00588024